Gertrude Belle Elion. 23 January 1918 — 21 February 1999

@article{Avery2008GertrudeBE,
  title={Gertrude Belle Elion. 23 January 1918 — 21 February 1999},
  author={Mary Ellen Avery},
  journal={Biographical Memoirs of Fellows of the Royal Society},
  year={2008},
  pages={161 - 168}
}
  • M. Avery
  • Published 12 December 2008
  • Education
  • Biographical Memoirs of Fellows of the Royal Society
In the spring of 1933 Gertrude Elion graduated from high school and that summer she had to select a major subject before she could begin her freshman year at Hunter College. This posed a quandary for the future Nobel Prize recipient, as well as holder of 45 patents, 23 honorary degrees, and a long list of other honours: she had liked all her school subjects, making it difficult to select just one. ‘Iloved to learn everything, everything in sight and I was never satisfied that I knew everything… 
2 Citations

Nobel Prize Winners Who Contributed To Transplantation.

TLDR
Alexis Carrel’s success with organ grafts was not dependent on a new method of suturing but on his use of fine needles and suture material, his exceptional technical skill, and his obsession with strict asepsis.

Pathfinders in oncology from the first clinical use of single‐agent chemotherapy to the introduction of mammography

During the period from 1942 to 1962, treatment attempts with single‐agent chemotherapy such as nitrogen mustard and urethan gained limited application. However, the groundbreaking success with

References

SHOWING 1-10 OF 17 REFERENCES

Layer on layer: the Bruce F. Cain memorial Award lecture.

TLDR
In 1942, there was a convergence of both factual and conceptual information that seemed to suggest that the time was right to begin to investigate nucleic acid biosynthesis, and variants of the heterocyclic bases of the nucleic acids were proposed to be made, to see whether these, as probes, could reveal anything about nucleic Acid biosynthesis.

Mechanism of action and selectivity of acyclovir.

  • G. Elion
  • Biology, Chemistry
    The American journal of medicine
  • 1982

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

TLDR
Acycloguanosine triphosphate inhibits herpes simplex virus DNA polymerase (DNA nucleotidyltransferase) 10-30 times more effectively than cellular (HeLa S3) DNA polymerases, contributing to the drug's selectivity.

Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors

TLDR
These studies indicate that vinorelbine possesses antitumor activity against several glioma tumor xenografts with marked activity in a mismatch repair deficient-tumor.

Inhibition by acyclovir of herpes simplex virus type 2 morphologically transformed cell growth in tissue culture and tumor‐bearing animals

TLDR
Rat embryo fibroblasts morphologically transformed by herpes simplex virus type 2 (HSV‐2) and tumor‐derived cells were tested for ability to grow in the presence of 9‐(2‐hydroxyethoxymethyl) guanine (acyclovir) and preliminary data showed that the drug inhibited tumor development in newborn syngeneic rats inoculated with HSV‐ 2‐transformed cells.

The Preparation of Primary Amines

Although direct alkylation of ammonia by alkyl halides leads to 1o-amines, alternative procedures are preferred in many cases. These methods require two steps, but they provide pure product, usually

Actions of purine analogs: enzyme specificity studies as a basis for interpretation and design.

TLDR
The importance of quantitative studies of the specificities of purine-metabolizing enzymes are discussed, and they may also serve as a basis for understanding the selective toxicity of a compound and aid in the design of new antimetabolites.